Mayne Pharma Group (MYX) is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialize branded and generic pharmaceuticals.
Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide.